Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor

INTRODUCTION: Many second-line treatments for advanced non-small-cell lung cancer (NSCLC) have been assessed in randomised controlled trials, but which treatments work the best remains unclear. Novel treatments are being rapidly developed. We need a comprehensive up-to-date evidence synthesis of all...

Descripción completa

Detalles Bibliográficos
Autores principales: Créquit, Perrine, Trinquart, Ludovic, Ravaud, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985872/
https://www.ncbi.nlm.nih.gov/pubmed/27489157
http://dx.doi.org/10.1136/bmjopen-2016-011841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985872/
https://www.ncbi.nlm.nih.gov/pubmed/27489157
http://dx.doi.org/10.1136/bmjopen-2016-011841

Ejemplares similares